Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of ethylenediaminetetraacetic acid-treated desmoglein ELISA and conventional desmoglein ELISA in the evaluation of pemphigus vulgaris in remission.
Daneshpazhooh M, Mahmoudi H, Balighi K, Teimourpour A, Khodashenas Z, Ghiasi M, Khosravi H, Chams-Davatchi C. Daneshpazhooh M, et al. Among authors: teimourpour a. J Am Acad Dermatol. 2018 Oct;79(4):768-770. doi: 10.1016/j.jaad.2018.03.035. Epub 2018 Mar 30. J Am Acad Dermatol. 2018. PMID: 29609015 No abstract available.
Estimated cut-off values for pemphigus severity classification according to pemphigus disease area index (PDAI), autoimmune bullous skin disorder intensity score (ABSIS), and anti-desmoglein 1 autoantibodies.
Mohebi F, Tavakolpour S, Teimourpour A, Toosi R, Mahmoudi H, Balighi K, Ghandi N, Ghiasi M, Nourmohammadpour P, Lajevardi V, Abedini R, Azizpour A, Nasimi M, Daneshpazhooh M. Mohebi F, et al. Among authors: teimourpour a. BMC Dermatol. 2020 Oct 31;20(1):13. doi: 10.1186/s12895-020-00105-y. BMC Dermatol. 2020. PMID: 33129291 Free PMC article.
Elevated serum level of B-cell activating factor (BAFF) after rituximab therapy in pemphigus vulgaris patients suggests a possible therapeutic efficacy of B-cell depletion therapies combined with anti-BAFF agents.
Daneshvar E, Tavakolpour S, Mahmoudi H, Daneshpazhooh M, Teimourpour A, Aslani S, Balighi K. Daneshvar E, et al. Among authors: teimourpour a. Int J Dermatol. 2023 Apr;62(4):567-574. doi: 10.1111/ijd.16363. Epub 2022 Jul 27. Int J Dermatol. 2023. PMID: 35894225
Lichen planopilaris: retrospective study on the characteristics and treatment of 291 patients.
Babahosseini H, Tavakolpour S, Mahmoudi H, Balighi K, Teimourpour A, Ghodsi SZ, Abedini R, Ghandi N, Lajevardi V, Kiani A, Kamyab K, Mohammadi M, Daneshpazhooh M. Babahosseini H, et al. Among authors: teimourpour a. J Dermatolog Treat. 2019 Sep;30(6):598-604. doi: 10.1080/09546634.2018.1542480. Epub 2019 Jan 4. J Dermatolog Treat. 2019. PMID: 30411987
40 results